Hematological Malignancies

Bendamustine in Rituximab refractory FL

100 patients rituximab refractory Bendamustine: 120 mg/m 2 ORR: 75% CR: 14% Median PFS: 9 months

Kahl BS, et al. Cancer. 2010;116(1):106-114.